CVS Health Corporation
$77.63
▲
0.35%
2026-04-22 10:12:13
www.cvshealth.com
NYQ: CVS
Explore CVS Health Corporation stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$99.22 B
Current Price
$77.63
52W High / Low
$85.15 / $58.35
Stock P/E
55.78
Book Value
$59.18
Dividend Yield
3.47%
ROCE
6.3%
ROE
2.29%
Face Value
—
EPS
$1.39
Exp Qtr EPS
—
Sector
Healthcare
Industry
Healthcare Plans
Employees
219,000
Beta
0.51
Debt / Equity
106.06
Current Ratio
0.84
Quick Ratio
0.63
Forward P/E
9.71
Price / Sales
0.25
Enterprise Value
$170.44 B
EV / EBITDA
11.65
EV / Revenue
0.43
Rating
Strong Buy
Target Price
$96.5
EPS Forecast (FY)
—
Pros
- Meaningful dividend yield is available.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Current ratio suggests tighter short-term liquidity.
- Operating margin is thin.
- Net margin is relatively low.
- Valuation is rich on a P/E basis.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Oscar Health, Inc. | $16.44 | — | $4.9 B | — | — | -44.35% | $23.8 / $10.69 | $3.29 |
| 2. | Progyny, Inc. | $18.64 | 24.25 | $1.42 B | — | 15.79% | 12.48% | $28.75 / $16.1 | $6.24 |
| 3. | Clover Health Investments, Corp. | $2.23 | — | $1.15 B | — | -25.75% | -26.33% | $3.92 / $1.58 | $0.59 |
| 4. | UnitedHealth Group Incorporated | $354.97 | 26.8 | $323.02 B | 2.73% | 9.74% | 12.54% | $489.79 / $234.6 | $103.87 |
| 5. | Humana Inc. | $216 | 21.97 | $26.04 B | 1.68% | — | 7.04% | $315.35 / $163.11 | $146.42 |
| 6. | Alignment Healthcare, Inc. | $21.56 | — | $4.34 B | — | 2.9% | -0.7% | $23.87 / $11.62 | $0.88 |
| 7. | Centene Corporation | $39.26 | — | $19.34 B | — | -0.78% | -28.68% | $64.15 / $25.08 | $40.58 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 105.69 B | 102.87 B | 98.92 B | 94.59 B | 97.71 B | — |
| Operating Profit | 2.11 B | 2.52 B | 2.38 B | 3.37 B | 2.48 B | — |
| Net Profit | 2.94 B | -3.98 B | 1.02 B | 1.78 B | 1.64 B | — |
| EPS in Rs | 2.3 | -3.1 | 0.8 | 1.39 | 1.28 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 402.07 B | 372.81 B | 357.78 B | 322.47 B |
| Operating Profit | 10.38 B | 9.7 B | 14.6 B | 16.29 B |
| Net Profit | 1.77 B | 4.61 B | 8.34 B | 4.31 B |
| EPS in Rs | 1.38 | 3.6 | 6.51 | 3.36 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 253.54 B | 253.22 B | 249.73 B | 228.28 B |
| Total Liabilities | 178.16 B | 177.49 B | 173.09 B | 156.51 B |
| Equity | 75.21 B | 75.56 B | 76.46 B | 71.47 B |
| Current Assets | 74.71 B | 68.64 B | 67.86 B | 65.63 B |
| Current Liabilities | 88.69 B | 84.61 B | 79.19 B | 69.42 B |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 10.64 B | 9.11 B | 13.43 B | 16.18 B |
| Investing CF | -5.87 B | -7.61 B | -20.89 B | -5.05 B |
| Financing CF | -4.94 B | -1.14 B | 2.68 B | -10.52 B |
| Free CF | 7.81 B | 6.33 B | 10.39 B | 13.45 B |
| Capex | -2.83 B | -2.78 B | -3.03 B | -2.73 B |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 4.2% | 10.95% | — | — |
| Earnings Growth % | -44.7% | 93.55% | — | — |
| Profit Margin % | 1.24% | 2.33% | 1.34% | — |
| Operating Margin % | 2.6% | 4.08% | 5.05% | — |
| Gross Margin % | 13.79% | 15.21% | 16.9% | — |
| EBITDA Margin % | 3.68% | 5.09% | 3.83% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2026-01-22 | $0.665 |
| 2025-10-23 | $0.665 |
| 2025-07-22 | $0.665 |
| 2025-04-22 | $0.665 |
| 2025-01-23 | $0.665 |
Stock Splits
No stock split history available.